Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/31/2007CN100345970C Receptor based antagonists and mehtods of making and using
10/31/2007CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007CN100345859C Antitumor compound nobiliside A from Holathuria nobilis and its monoacetylated derivative
10/31/2007CN100345852C Quinolinyl-pyrrolopyrazoles
10/31/2007CN100345850C Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345830C Condensed heteroaryl derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345827C Bicyclic aromatic compound
10/31/2007CN100345810C Novel natural drug effective region of rabdosiaexcisa total diterpene
10/31/2007CN100345592C Mono and disaccharide derivatives
10/31/2007CN100345577C Preparation method of high allicin garlic powder capsule
10/31/2007CN100345547C Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
10/31/2007CN100345537C Application wogonin for preparing medicine to treat leukaemia
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007US7288633 To induce the activities of B cells and T cells in therapy of immune deficiency disorders, viral infections, and bacterial infections
10/30/2007US7288631 G-coupled receptor showing selective affinity for ATP
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288568 Alzheimer's disease; Parkinson's disease; inflammatory bowel disease; antiarthritic agents
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288565 Azasugar compound
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288550 Administering 2-butyl-1-[5-(methylsulfonyl)pentyl]-1H-imidazo[4,5-c]quinolin-4-amine or salts to induce biosynthesis of cytokines such as IFN- alpha and/or TNF- alpha; treating viral diseases
10/30/2007US7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
10/30/2007US7288534 Sphingomyelin enhancement of tumor therapy
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007US7288251 Antibodies to CD40
10/30/2007CA2509650C C-6 modified indazolylpyrrolotriazines
10/30/2007CA2382106C Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
10/30/2007CA2377293C Real-time monitoring of photodynamic therapy over an extended time
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/30/2007CA2145397C Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
10/30/2007CA2136140C Carcinostatic for hormonotherapy containing dienogest as effective component
10/25/2007WO2007120827A2 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders
10/25/2007WO2007120760A2 Thiophene-carboxamides useful as inhibitors of protein kinases
10/25/2007WO2007120693A2 Targeted binding agents directed to upar and uses thereof
10/25/2007WO2007120669A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
10/25/2007WO2007120593A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007WO2007120339A1 Pyrimidine kinase inhibitors
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007WO2007119859A1 Protein complex and process for production thereof
10/25/2007WO2007119815A1 Toll-like receptor 9 agonists
10/25/2007WO2007119796A1 Mutant polypeptide having effector function
10/25/2007WO2007119754A1 Agent for prevention or treatment of leukemia and beverage/food
10/25/2007WO2007119692A1 METHOD OF INHIBITING CANCER CELL PROLIFERATION BY REGULATING eIF4H EXPRESSION
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119564A1 siRNA SPECIFIC TO WT1 17AA(-)ISOFORM AND USE THEREOF
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119214A2 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
10/25/2007WO2007119055A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
10/25/2007WO2007119046A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
10/25/2007WO2007119027A1 Calixarene derivatives as anticancer agent
10/25/2007WO2007119006A1 New medicines for treatments against retroviruses
10/25/2007WO2007118947A1 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone
10/25/2007WO2007118884A1 Magnetic nanoparticles compositions and uses thereof
10/25/2007WO2007118844A1 Substituted pyrazolopyrimidines, process for their preparation and their use for controlling harmful fungi and compositions comprising them
10/25/2007WO2007118793A1 Dihydrothienopyrimidine for treating inflammatory disorders
10/25/2007WO2007118660A2 Her-2/neu multi-peptide vaccine
10/25/2007WO2007118335A1 Hepoxilin analog enantiomers
10/25/2007WO2007090095A3 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
10/25/2007WO2007073518A3 Compounds and methods for thiol-containing compound efflux and cancer treatment
10/25/2007WO2007072153A3 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
10/25/2007WO2007066784A3 Diarylether derivatives as antitumor agents
10/25/2007WO2007049043A3 Tnf alpha ngf molecular switch for determining cell fate
10/25/2007WO2007038788A3 Small interfering rnas as non-specific drugs
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249708 C7 ester and c10 hydroxy substituted taxanes
10/25/2007US20070249707 Taxanes having c7 hydroxy and c10 heterosubstituted acetate substituents
10/25/2007US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249676 Cyanoguanidine prodrugs
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249652 Phenanthridinium Derivatives as Dna Binding Agents
10/25/2007US20070249651 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
10/25/2007US20070249650 isolating and purifying quaternary ammonium alkaloid species from medicinal plant of Yan Huang Lian (Corydalis saxicola Bounting) through solvent extraction, crystallization and recrystallization; for treating viral hepatitis, hepatic injury, influenza, AIDS, tumors or arrhythmia
10/25/2007US20070249641 Adenosine a3 receptor modulators
10/25/2007US20070249636 Selected Fused Heterocyclics and Uses Thereof
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249613 Reduction of Toxicity of Multi-Targeting Antifolates
10/25/2007US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249564 Novel phosphorus-containing prodrugs
10/25/2007US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides
10/25/2007US20070249541 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
10/25/2007US20070249540 Methods for Inhibiting Proteasome and Heat Shock Protein 90
10/25/2007US20070249535 Methods for treating bone tumors
10/25/2007US20070249031 Aminopyrimidines useful as kinase inhibitors
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070248988 Binding molecules and methods of use thereof
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248705 Agents for Activating the Transcription Factor Nrf2 and Foods Having Such Function
10/25/2007US20070248693 Nutraceutical composition and method of use for treatment / prevention of cancer
10/25/2007US20070248692 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007US20070248628 Immunogens in cancer stem cells
10/25/2007US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007US20070248620 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 2211